Siemens Healthineers AG

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. It operates through the following business segments: Imaging, Diagnotics, Varian and Advanced Therapies. The Imaging segment provides imaging products, services, and solutions as well as digital offerings. The Diagnostics segment provides a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Varian segment provides innovative, multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments in hospitals and clinics globally. The Advanced Therapies segment consist of integrated products, services and solutions across multiple clinical fields used in the treatment of diseases. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Forchheim, Germany.

MALVERN, Pa. & IOWA CITY, Iowa--(BUSINESS WIRE)--Siemens Healthineers and University of Iowa Health Care have established a 10-year Value Partnership that builds on a long-standing relationship and will help advance care in Iowa over the next decade. The partnership will provide Iowans with access to cutting-edge imaging technology; use artificial intelligence and data analytics to improve performance and efficiency; expand research opportunities; and invest in workforce training and developmen

Siemens Healthineers and University of Iowa Health Care Team Up to Advance Care for Iowans Over the Next Decade

MALVERN, Pa. & RALEIGH, N.C.--(BUSINESS WIRE)--Siemens Healthineers and WakeMed Health & Hospitals have established a 10-year, patient-focused, Value Partnership to innovate care delivery and improve patient outcomes through robotics initiatives, advanced imaging capabilities and artificial intelligence, along with provider and staff training. A trusted leader and innovator for more than 50 years, WakeMed is the first health system in N.C. to serve as a Siemens Healthineers Value Partnershi

Siemens Healthineers and WakeMed Announce Innovative Relationship to Advance Care and Improve Outcomes

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers announced today a collaboration with the U.S.

Siemens Healthineers Collaboration With CDC Will Define Threshold for Neutralizing Antibody Sufficient to Confer Immunity

MALVERN, Pa.--(BUSINESS WIRE)--The Food and Drug Administration (FDA) has cleared the SOMATOM On.site, a mobile head computed tomography (CT) scanner from Siemens Healthineers that enables a critically ill patient to receive CT head imaging in the intensive care unit (ICU) while remaining in bed.

FDA Clears SOMATOM On.site from Siemens Healthineers For CT Head Exams at Patient’s Bedside

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers announced today that it received FDA Emergency Use Authorization (EUA) for the SARS-CoV-2 IgG (COV2G) antibody test.2 This is the first antibody test authorized with a semi-quantitative detection claim and the fifth antibody test from the company to receive EUA that offers sensitivity and specificity of greater than 99 percent.

Siemens Healthineers Obtains First FDA EUA for Semi-Quantitative Antibody Test

Siemens AG

Siemens Healthineers AG (SEMHF) CEO Bernhard Montag on Q3 2020 Results - Earnings Call Transcript

Varian Medical Systems

Why Varian Medical Systems Stock Surged Today

NEW YORK, Aug. 3, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Varian Medical Systems, Inc.

Varian Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Varian Medical Systems, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm

NEW YORK--(BUSINESS WIRE)--Rowley Law PLLC is investigating potential securities law violations by Varian Medical Systems, Inc. (NYSE: VAR) and its board of directors concerning the proposed acquisition of the company by Siemens Healthineers AG.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Varian Medical Systems, Inc.

Siemens Healthineers plans a two-step capital increase to raise 7.5 billion euros ($8.80 billion) via share placements to help finance its acquisition of Varian Medical Systems , sources close to the matter said on Monday.

Siemens Healthineers plans two-step 7.5 billion euro capital hike for Varian acquisition: sources

New York, New York--(Newsfile Corp. - August 3, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To view an enhanced version of this graphic, please visit:https://orders.newsfilecorp.com/files/7091/60956_7645439484542bdb_001full.jpgTo: All Persons or Entities

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Varian Medical Systems, Inc. to Siemens Healthineers AG

Varian Medical Systems, Inc (NYSE: VAR) announced Sunday that Siemens Healthineers AG (OTC: SMMNY) would purchase it in an all-cash transaction valued at $16.4 billion.

Germany's Siemens Healthineers To Acquire Varian Medical In $16.4B All-Cash Deal

German health group Siemens Healthineers said on Sunday it would acquire Varian Medical Systems Inc in a deal that values the U.S. maker of devices and software fortreating cancer at $16.4 billion.

Siemens Healthineers to acquire Varian for $16.4 billion

PALO ALTO, Calif., Aug. 2, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it has entered into a definitive agreement to combine with Siemens Healthineers AG (Frankfurt: SHL) in an all-cash transaction valued at $16.4 billion on a fully diluted basis.

Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction

German group Siemens Healthineers AG is in advanced talks to purchase Varian Medical Systems Inc , a maker of devices and software for treating cancer, in a deal that will value the medical device maker at about $15 billion, Bloomberg News reported late on Saturday.

Siemens Healthineers in advanced talks to buy Varian for $15 billion: Bloomberg News

News for Siemens Healthineers AG Stock (SMMNY)